ERNA vs TXN · P/E 0.0, rev $582.0K vs P/E 52, rev $17.68B
Eterna Therapeutics Inc (ERNA) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the ERNA and TXN stock pages for the full models.
Not investment advice.